Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPB with liposomal bupivacaine vs ropivacaine + dexamethasone for analgesia after uniportal VATS lobectomy
ChiCTR2600122550Phase 4Recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Liposomal bupivacaine SAPB with Ropivacaine + dexamethasone SAPB (2 arms). Primary endpoint: Morphine milligram equivalents of opioid consumption postoperatively. Started Apr 2026; status: recruiting.
02
Drugs
bupivacaineropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600122550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122550.